{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:47:27Z","timestamp":1791478047951,"version":"4.3.4"},"reference-count":23,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Spinal stenosis, low back pain, and radiating pain to the lower extremities are caused by inflammation of the spinal canal and impaired blood flow around the nerves. Because JOINS tablets are known to have anti-inflammatory, pain-relieving, and blood circulation-enhancing properties, this research was conducted based on the assumption that they could improve spinal stenosis. Materials and Methods: This was a prospective, randomized, single-center, open-label clinical trial with a 6-month follow-up period. A total of 100 patients with lumbar spinal stenosis were randomized into two groups: 50 patients in the test group and 50 patients in the control group. The control group was prescribed the usual spinal stenosis medications (Naproxen, Limaprost, and Pregabalin), while the test group was prescribed JOINS tablets in addition to the usual medications. Results: The severity of low back pain and radiating leg pain was assessed using a Visual Analog Scale. Spinal functional outcomes were assessed using the Oswestry Disability Index (ODI) and Roland-Morris Disability Questionnaire (RMDQ), and quality of life was assessed using the Short Form 36 (SF-36), with division into Physical Component Score (PCS) and Mental Component Score (MCS). At 6 months, the JOINS group showed a greater reduction in low back pain compared with controls (p &lt; 0.001). At all follow-up periods, the functional outcomes did not show statistically significant differences between the test and control groups. Conclusions: The significant reduction in pain suggests that JOINS tablets may be an effective adjunct for pain relief, particularly in patients at high risk of adverse effects from long-term NSAID use.<\/jats:p>","DOI":"10.3390\/medicina61111900","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:47:36Z","timestamp":1761266856000},"page":"1900","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of JOINS Tablet for Lumbar Spinal Stenosis: Prospective, Randomized, Open-Label Clinical Trial"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3527-9251","authenticated-orcid":false,"given":"Sangbong","family":"Ko","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, Daegu Catholic University Medical Center, Daegu 42472, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2210-0662","authenticated-orcid":false,"given":"Heechan","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Armed Forced Daegu Hospital, Gyeongsan 38427, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1001\/jama.2022.5921","article-title":"Diagnosis and Management of Lumbar Spinal Stenosis: A Review","volume":"327","author":"Katz","year":"2022","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00586-017-5374-2","article-title":"Correlations between sedimentation sign, dural sac cross-sectional area, and clinical symptoms of degenerative lumbar spinal stenosis","volume":"27","author":"Ko","year":"2017","journal-title":"Eur. Spine J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jpain.2021.03.147","article-title":"Non-Surgical Interventions for Lumbar Spinal Stenosis Leading To Neurogenic Claudication: A Clinical Practice Guideline","volume":"22","author":"Cancelliere","year":"2021","journal-title":"J. Pain"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bcpt.12244","article-title":"The impact of NSAID Treatment on Cardiovascular Risk\u2014Insight from Danish observation data","volume":"115","author":"Olsen","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.31616\/asj.2022.0366","article-title":"Lumbar Spinal Stenosis: Review Update 2022","volume":"16","author":"Kwon","year":"2022","journal-title":"Asian Spine J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1142\/S0192415X01000502","article-title":"Effect of SKI 306X, a new herbal anti-arthritic agent, in patients with osteoarthritis of the knee: A double-blind placebo controlled study","volume":"29","author":"Jung","year":"2001","journal-title":"Am. J. Chin. Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Quan, J., He, C.J., Kim, J.Y., Lee, J.Y., Kim, C.J., Jeon, Y.J., Im, C.W., Lee, D.K., Kim, J.E., and Park, H.J. (2024). Analgesic Effect of SKI306X on Chronic Postischemic Pain and Spinal Nerve Ligation-Induced Neuropathic Pain in Mice. Biomedicines, 12.","DOI":"10.3390\/biomedicines12071379"},{"key":"ref_8","first-page":"32","article-title":"Acute toxicity of SKI306X, an anti-inflammatory herbal extract, in rats","volume":"1","author":"Ahn","year":"1996","journal-title":"J. Appl. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/joca.2002.0526","article-title":"Effects of SKI 306X, a new herbal agent, on proteoglycan degradation in cartilage explant culture and collagenase-induced rabbit osteoarthritis model","volume":"10","author":"Choi","year":"2002","journal-title":"Osteoarthr. Cartil."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3904\/kjim.2014.29.5.647","article-title":"SKI306X inhibition of glycosaminoglycan degradation in human cartilage involves down-regulation of cytokine-induced catabolic genes","volume":"29","author":"Choi","year":"2014","journal-title":"Korean J. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1254\/jphs.FPJ04058X","article-title":"SKI306X suppresses cartilage destruction and inhibits the production of matrix metalloproteinase in rabbit joint cartilage explant culture","volume":"98","author":"Kim","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5792\/ksrr.17.004","article-title":"Efficacy of JOINS on Cartilage Protection in Knee Osteoarthritis: Prospective Randomized Controlled Trial","volume":"29","author":"Kim","year":"2017","journal-title":"Knee Surg. Relat. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"118843","DOI":"10.1016\/j.jep.2024.118843","article-title":"Efficacy and safety of SKCPT in patients with knee osteoarthritis: A multicenter, randomized, double-blinded, active-controlled phase III clinical trial","volume":"337","author":"Bin","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4078\/jrd.2023.0084","article-title":"Medical treatment of osteoarthritis: Botanical pharmacologic aspect","volume":"31","author":"Park","year":"2024","journal-title":"J. Rheum. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Park, Y.B., and Kim, J.H. (2025). Efficacy and Safety of Celecoxib and a Korean SYSADOA (JOINS) for the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis. J. Clin. Med., 14.","DOI":"10.3390\/jcm14041036"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s11926-012-0288-9","article-title":"Intersection of inflammation and herbal medicine in the treatment of osteoarthritis","volume":"14","author":"Mobasheri","year":"2012","journal-title":"Curr Rheumatol Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.lfs.2004.11.040","article-title":"SKI306X, an oriental herbal mixture, suppresses gastric leukotriene B4 synthesis without causing mucosal injury and the diclofenac-induced gastric lesions","volume":"77","author":"Kim","year":"2005","journal-title":"Life Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jep.2017.06.003","article-title":"Evaluation of cardiovascular risk associated with SKI306X use in patients with osteoarthritis and rheumatoid arthritis","volume":"207","author":"Woo","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1878-5085-5-10","article-title":"The review of innovative integration of Kampo medicine and Western medicine as personalized medicine at the first multidisciplinary pain center in Japan","volume":"5","author":"Arai","year":"2014","journal-title":"EPMA J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/acm.2016.0276","article-title":"Goshajinkigan for low back pain: An observational study","volume":"23","author":"Hamaguchi","year":"2017","journal-title":"J. Altern. Complement. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40981-017-0130-5","article-title":"Japanese traditional herbal medicine reduces use of pregabalin and opioids for pain in patients with lumbar spinal canal stenosis: A retrospective cohort study","volume":"3","author":"Oohata","year":"2017","journal-title":"JA Clin. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/jcm10010074","article-title":"Long-Term Follow-Up of Spinal Stenosis Inpatients Treated with Integrative Korean Medicine Treatment","volume":"10","author":"Kim","year":"2020","journal-title":"J. Clin. Med."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Schulz, K.F., Altman, D.G., Moher, D., and CONSORT Group (2010). CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. BMC Med., 8.","DOI":"10.1186\/1741-7015-8-18"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/11\/1900\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T01:31:06Z","timestamp":1761269466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/11\/1900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":23,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["medicina61111900"],"URL":"https:\/\/doi.org\/10.3390\/medicina61111900","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]}}}